University of Basel
University of Basel
Location: Basel - North West Switzerland
- Basel Natural History Museum
- Institute of Molecular and Clinical Ophthalmology Basel (IOB)
- NCCR Iconic Criticism
- Swiss TPH
- University Hospital Basel
The University of Basel is a university which performs excellently in research and teaching. Founded in 1460, Switzerland’s oldest university has over 550 years of successful history.
As a university offering a wide range of quality education, it attracts students from Switzerland and all around the world and offers them excellent study conditions at undergraduate, graduate and doctoral level. Today, the University of Basel counts around 13,000 students coming from over one hundred nations.
» Job Offers: University of Basel
Last job offers
Program Officer - Peacebuilding Analysis & Impact University of Basel
Wissenschaftliche Assistenz in Musikwissenschaft / Neuere Musikgeschichte University of Basel
Postdoc in Sportwissenschaft (Bereich Sport- und Bewegungsmedizin) University of Basel
Assistenz im Fachbereich Syst. Theologie / Ethik University of Basel
PhD Candidate in Epidemiology to join the Society, Gender and Health Unit University of Basel
Senior Immunisation specialist National Position based in Cameroon University of Basel
Assistenz (60%) für Geschichte der Frühen Neuzeit University of Basel
Hilfsassistenz University of Basel
PhD position in Biomedicine - Mechanisms of Therapeutic Angiogenesis University of Basel
Scientific IT Infrastructure / DevOps Specialist University of Basel
Remdesivir was one of the first medications approved for treatment of COVID-19. Clinical studies evaluated its effectiveness, but did not generate conclusive results. A new analysis of the study data shows that a specific group of patients benefits the most from the drug.
Guilt is an uncomfortable feeling and can be burdensome. Researchers at the University of Basel have shown that placebos can help reduce feelings of guilt, even when the placebo is administered openly.
For many people in Switzerland, holidays in the snow are as much a part of the end of the year as Christmas trees and fireworks. As global warming progresses, however, white slopes are becoming increasingly rare. Researchers at the University of Basel have calculated how well one of Switzerland's largest ski resorts will remain snow reliable with technical snowmaking by the year 2100, and how much water this snow will consume.
Global warming is leading to longer growing seasons worldwide, with many plants growing earlier in spring and continuing longer in autumn thanks to warmer temperatures-so the general opinion. Now, however, plant ecologists at the University of Basel have been able to show that this is not the case for the most common type of alpine grassland in the European Alps, where an earlier start leads to earlier aging and leaves the grassland brown for months.
When it comes to chronic infections and cancer, a particular type of immune cell plays a central role in our defenses. Researchers at the University of Basel have uncovered the key to the tenacity of these immune cells in coping with the marathon that is fighting a chronic infection. Their results lay the foundations for more effective therapies and vaccination strategies.
The autoimmune disease multiple sclerosis can take a variety of courses. Determining the current and future course of the disease is important in order to slow down its course as much as possible. Researchers at the University of Basel have presented a biomarker whose values in the blood allow such predictions.
Private patients receive treatment for heart conditions more often than those with basic health insurance
Patients in Switzerland with supplementary private health insurance are more likely to undergo cardiac procedures than those with only basic health insurance. This has been demonstrated in a study by researchers from the University of Basel and the Cantonal Hospital of Aarau.
’For a long time, the professors were unwilling to recognize the sheer criminality of the new regime.’
Rectal artesunate, a promising antimalarial drug, has no beneficial effect on the survival of young children with severe malaria when used as an emergency treatment in resource-constrained settings. These are the results of a large-scale study conducted by the Swiss Tropical and Public Health Institute and local partners in three African countries.